| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |